Equities Research Analysts’ price target changes for Tuesday, December 5th:

Bristol-Myers Squibb (NYSE:BMY) was given a $72.00 target price by analysts at Citigroup Inc.. The firm currently has a buy rating on the stock.

Caterpillar (NYSE:CAT) was given a $155.00 target price by analysts at UBS AG. The firm currently has a buy rating on the stock.

Columbia Sportswear (NASDAQ:COLM) was given a $77.00 price target by analysts at DA Davidson. The firm currently has a buy rating on the stock.

Dialog Semiconductor (ETR:DLG) was given a €28.00 ($33.33) target price by analysts at Main First Bank AG. The firm currently has a buy rating on the stock.

Fortress Biotech (NASDAQ:FBIO) was given a $11.00 price target by analysts at HC Wainwright. The firm currently has a buy rating on the stock.

Jernigan Capital (NYSE:JCAP) was given a $25.00 target price by analysts at B. Riley. The firm currently has a buy rating on the stock.

Kindred Biosciences (NASDAQ:KIN) was given a $11.00 price target by analysts at B. Riley. The firm currently has a buy rating on the stock.

Kindred Biosciences (NASDAQ:KIN) was given a $10.00 price target by analysts at HC Wainwright. The firm currently has a buy rating on the stock.

Micron Technology (NASDAQ:MU) was given a $50.00 price target by analysts at Cowen Inc. The firm currently has a buy rating on the stock.

Paychex (NASDAQ:PAYX) had its price target raised by Bank of America Corp from $68.00 to $73.00. Bank of America Corp currently has a buy rating on the stock.

Revance Therapeutics (NASDAQ:RVNC) was given a $50.00 price target by analysts at Cantor Fitzgerald. The firm currently has a buy rating on the stock.

Shire (NASDAQ:SHPG) was given a $222.00 target price by analysts at Cantor Fitzgerald. The firm currently has a buy rating on the stock.

SL Green Realty (NYSE:SLG) was given a $117.00 target price by analysts at SunTrust Banks, Inc.. The firm currently has a buy rating on the stock.

Sunesis Pharmaceuticals (NASDAQ:SNSS) was given a $3.00 price target by analysts at Cantor Fitzgerald. The firm currently has a hold rating on the stock.

Axel Springer (FRA:SPR) was given a €66.00 ($78.57) target price by analysts at Morgan Stanley. The firm currently has a neutral rating on the stock.

Receive News & Ratings for Bristol-Myers Squibb Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bristol-Myers Squibb Company and related companies with MarketBeat.com's FREE daily email newsletter.